Originally published by our sister publication Infectious Disease Special Edition
The FDA approved ceftobiprole medocaril sodium for injection (Zevtera, Basilea Pharmaceutica International) for three different indications.
Ceftobiprole medocaril is indicated for the treatment of adults with bacteremia caused by Staphylococcus aureus, including those with right-sided infective endocarditis, adults with acute bacterial skin and skin structure infections (ABSSSI), and adults and children 3